Normal Pressure Hydrocephalus Associated with Alzheimer's Disease

The aim was to investigate whether neurodegenerative biomarkers in cerebrospinal fluid (CSF) differentiate patients with suspected normal pressure hydrocephalus (NPH) who respond to CSF drainage from patients who do not respond.

[1]  C. Cullum,et al.  Clinical outcomes of normal pressure hydrocephalus in 116 patients: objective versus subjective assessment. , 2020, Journal of neurosurgery.

[2]  Q. Jiang,et al.  Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human , 2020, Annals of neurology.

[3]  E. Shimosegawa,et al.  Cerebral blood flow and Alzheimer's disease‐related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus , 2019, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[4]  R. Seitz,et al.  Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[5]  P. Mazzoni,et al.  Predicting Cognitive Improvement in Normal Pressure Hydrocephalus Patients Using Preoperative Neuropsychological Testing and Cerebrospinal Fluid Biomarkers. , 2019, Neurosurgery.

[6]  P. Eide,et al.  Delayed clearance of cerebrospinal fluid tracer from choroid plexus in idiopathic normal pressure hydrocephalus , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  L. Chiari,et al.  A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study. , 2019, Parkinsonism & related disorders.

[8]  P. Eide,et al.  Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: A glymphatic magnetic resonance imaging study , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  K. Blennow,et al.  CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  L. Söderström,et al.  Prevalence of idiopathic normal pressure hydrocephalus: A prospective, population-based study , 2019, PloS one.

[11]  T. Takeuchi,et al.  Long-term 4 Years Follow-up Study of 482 Patients Who Underwent Shunting for Idiopathic Normal Pressure Hydrocephalus -Course of Symptoms and Shunt Efficacy Rates Compared by Age Group- , 2019, Neurologia medico-chirurgica.

[12]  R. Nitrini,et al.  Normal-pressure hydrocephalus: A critical review , 2019, Dementia & neuropsychologia.

[13]  Keith A. Johnson,et al.  Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau , 2019, Annals of neurology.

[14]  J. Trojanowski,et al.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders , 2018, Annals of neurology.

[15]  Keith A. Johnson,et al.  The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals , 2018, Annals of neurology.

[16]  J. Marquez,et al.  Cognitive and upper limb symptom changes from a tap test in Idiopathic Normal Pressure Hydrocephalus , 2018, Clinical Neurology and Neurosurgery.

[17]  R. Seitz,et al.  Physiotherapy and Occupational Therapy in Acute Neurology , 2018, Neurology International Open.

[18]  A. Lang,et al.  Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration , 2017, Annals of neurology.

[19]  C. Saper.  Is there even such a thing as “Idiopathic normal pressure hydrocephalus”? , 2017, Annals of neurology.

[20]  Per Kristian Eide,et al.  Glymphatic MRI in idiopathic normal pressure hydrocephalus , 2017, Brain : a journal of neurology.

[21]  H. Kishima,et al.  Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus , 2016, Journal of the Neurological Sciences.

[22]  C. Wikkelsø,et al.  Vascular factors in suspected normal pressure hydrocephalus , 2016, Neurology.

[23]  J. Jane,et al.  Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes. , 2016, Journal of neurosurgery.

[24]  S. Tibaek,et al.  Reference values of maximum walking speed among independent community-dwelling Danish adults aged 60 to 79 years: a cross-sectional study. , 2015, Physiotherapy.

[25]  M. Davidson,et al.  Reliability and validity of the German translation of the de Morton Mobility Index (DEMMI) performed by physiotherapists in patients admitted to a sub-acute inpatient geriatric rehabilitation hospital , 2015, BMC Geriatrics.

[26]  R. Kressig,et al.  Motor cognitive dual tasking , 2015, Zeitschrift für Gerontologie und Geriatrie.

[27]  Kyunghun Kang,et al.  Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test , 2014, Journal of Clinical Neuroscience.

[28]  O. Beauchet,et al.  Dual-task related gait changes after CSF tapping: a new way to identify idiopathic normal pressure hydrocephalus , 2013, Journal of NeuroEngineering and Rehabilitation.

[29]  N. Relkin,et al.  Diagnosis and management of idiopathic normal-pressure hydrocephalus. , 2013, Neurology. Clinical practice.

[30]  J. Ragheb,et al.  Nonoperative management of solitary eosinophilic granulomas of the calvaria. , 2013, Journal of neurosurgery. Pediatrics.

[31]  Andrew Kerr,et al.  The test-retest reliability of gait-related dual task performance in community-dwelling fallers and non-fallers. , 2013, Gait & posture.

[32]  A. Monsch,et al.  Early detection of Alzheimer’s disease with a total score of the German CERAD , 2010, Journal of the International Neuropsychological Society.

[33]  Chu Kim-prieto,et al.  New Well-being Measures: Short Scales to Assess Flourishing and Positive and Negative Feelings , 2010 .

[34]  J. Schwalb,et al.  Normal pressure hydrocephalus: Diagnosis and treatment , 2008, Current neurology and neuroscience reports.

[35]  G. Silverberg,et al.  Continuous CSF drainage in AD , 2008, Neurology.

[36]  C. Lueck,et al.  CSF opening pressure: Reference interval and the effect of body mass index , 2006, Neurology.

[37]  Richard W. Bohannon,et al.  Reference Values for the Timed Up and Go Test: A Descriptive Meta‐Analysis , 2006, Journal of geriatric physical therapy.

[38]  P. Catlin,et al.  Establishing the reliability and validity of measurements of walking time using the Emory Functional Ambulation Profile. , 1999, Physical therapy.

[39]  K. Shulman,et al.  Clock‐drawing and dementia in the community: A longitudinal study , 1993 .

[40]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[41]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[42]  R. D. Adams,et al.  The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. , 1965, Journal of the neurological sciences.

[43]  D. Wechsler.  Wechsler Adult Intelligence Scale , 2021, Encyclopedia of Evolutionary Psychological Science.

[44]  S. Hasselbalch,et al.  Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review. , 2019, Journal of Alzheimer's disease : JAD.

[45]  H. Soininen,et al.  [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus. , 2019, Journal of Alzheimer's disease : JAD.

[46]  L. Albini-Riccioli,et al.  Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study. , 2019, Journal of Alzheimer's disease : JAD.

[47]  D. Na,et al.  Prognostic value of amyloid PET scan in normal pressure hydrocephalus , 2017, Journal of Neurology.

[48]  G. Magnani,et al.  Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[49]  T. Brandt,et al.  Walking assessment after lumbar puncture in normal-pressure hydrocephalus: a delayed improvement over 3 days. , 2017, Journal of neurosurgery.

[50]  Robert Biswas-Diener,et al.  New Measures of Well-Being , 2009 .

[51]  G. Román,et al.  White matter lesions and normal-pressure hydrocephalus: Binswanger disease or Hakim syndrome? , 1991, AJNR. American journal of neuroradiology.